From concept to cure,
all in one place.
An early-stage biotechnology company bringing bioinformatics and gene editing together to investigate Crohn’s disease.
About ViroDyn
We investigate the biology behind disease to explore where new therapeutic possibilities could begin.
Our research focus
Crohn’s disease.
Early-stage researchViroDyn explores how genetic changes contribute to Crohn’s disease.
We bring bioinformatics and gene editing together to investigate those changes in the laboratory, asking whether correcting them can improve disease-relevant biology.
Use genetic and biological data to identify questions worth testing.
Use gene editing to investigate those questions in the laboratory.
Assess the biological results and use the evidence to guide the next experiment.
Our moonshot
Most medicine treats inflammation. We are going after what causes it.
We start with Crohn’s, where the genetics are clearest, and a method built to be repeated: select the target from patient data, correct it, measure whether it matters, decide on evidence rather than enthusiasm.
The disease is the first application. The method is the company.
Our focus today
Build the biological evidence through focused laboratory research.
Potential next applications
Explore where the approach could address related biological questions.
The wider ambition
Develop a research foundation that could be adapted across diseases with a genetic basis.
A long-term research ambition. Each new application would need its own biological evidence.
Our story
Alex Humphries, ViroDyn’s co-founder and scientific lead, lives with Crohn’s disease. For him, the questions behind the research are personal as well as scientific.
That perspective sits alongside ViroDyn’s research focus: using bioinformatics and laboratory investigation to explore the biology of Crohn’s disease.
Our team
Company builders, scientific specialists and advisers, working together around a shared research focus.
Leadership
Co-founder & Chief Executive Officer
Serial entrepreneur & co-founder
John is a serial entrepreneur and co-founder with experience in building technology companies and raising capital. At ViroDyn, he leads financing, partnerships and commercial strategy.
Leadership
Co-founder & Chief Scientific Officer
ViroDyn co-founder · Scientific strategy
Alex developed the scientific thesis behind ViroDyn’s Crohn’s disease programme. He leads the company’s scientific direction, connecting genetics, biological data and experimental planning.
Leadership
Co-founder & Chief Operating Officer
ViroDyn co-founder · Programme operations
Sinan connects ViroDyn’s research plans with practical delivery. He coordinates company operations, suppliers and programme planning, bringing laboratory requirements and execution together.
Lead scientists
Head of Quality Control & Lab Oversight
Assistant Professor in Genome Stability · University of Sussex
Owen is an Assistant Professor in Genome Stability at Sussex, with previous laboratory experience at Oxford Biomedica. At ViroDyn, he leads quality control and laboratory oversight.
University profile for Owen Wells (opens in a new tab)
Lead scientists
Lab Operations
Professor of Genome Stability · University of Sussex
Helfrid is Professor of Genome Stability at Sussex and leads its Cell Cycle Control Laboratory. His research examines how cells control division and maintain chromosome stability, combining genetics, biochemistry, microscopy and proteomics. At ViroDyn, he leads laboratory operations.
University profile for Helfrid Hochegger (opens in a new tab)
Advisers
Scientific Adviser
Principal Research Fellow · University of Sussex
Antony studies DNA repair through structural biology, biochemistry and biophysics at Sussex. He advises ViroDyn on assay selection, experimental controls and laboratory protocols.
University profile for Antony Oliver (opens in a new tab)
Advisers
Computational Adviser
Systems biology · Brighton and Sussex Medical School
Simon develops computational models of cell signalling, immunity and inflammation at Brighton and Sussex Medical School. He advises ViroDyn on integrating biological data and interpreting experimental findings.
University profile for Simon Mitchell (opens in a new tab)Contact
For research connections, questions about ViroDyn or investor enquiries, get in touch.
Introduce research, expertise or capabilities relevant to our work.
Email about collaborationHave a question about ViroDyn or our research focus?
Email your questionGet in touch to discuss our scientific direction and company plans.
Email an investor enquiry
